ES482421A1 - Un procedimiento para la preparacion de nuevos derivados de prostaglandina. - Google Patents
Un procedimiento para la preparacion de nuevos derivados de prostaglandina.Info
- Publication number
- ES482421A1 ES482421A1 ES482421A ES482421A ES482421A1 ES 482421 A1 ES482421 A1 ES 482421A1 ES 482421 A ES482421 A ES 482421A ES 482421 A ES482421 A ES 482421A ES 482421 A1 ES482421 A1 ES 482421A1
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- substituent
- hydrogen
- phenyl
- vinylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 prostaglandin carboxamides Chemical class 0.000 title abstract 7
- 150000001875 compounds Chemical class 0.000 abstract 5
- 230000000694 effects Effects 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 2
- 239000005977 Ethylene Substances 0.000 abstract 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
- 230000035558 fertility Effects 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000000767 anti-ulcer Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 125000000068 chlorophenyl group Chemical group 0.000 abstract 1
- 125000001207 fluorophenyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000003944 tolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un procedimiento para la preparación de nuevos derivados de prostaglandina, de fórmula I: **(Fórmula-01)** y opcionalmente para la preparación de una sal farmacológicamente aceptable del mismo donde: A es etileno o cis-vinileno; B es etileno o trans-vinileno; Y es hidrógeno o hidroxi; G es CH2Ar, Ch2OAr o CRZ(CH2)3CH3; Ar es fenilo, fluorfenilo, clorofenilo, metilfenilo, etilfenilo, metoxifenilo, etoxifenilo, bifenilo y trifluor metilfenilo; R es hidrógeno o metilo y Z es hidrógeno o metilo; cuyo procedimiento consiste en: hacer reaccionar un intermediario de fórmula (III): **(Fórmula-02)** donde A, B y G son los definidos anteriormente, con un reactivo de grupos salientes para formar un derivado de un grupo ácido carboxílico con un grupo saliente fácilmente desplazable, seguido de desplazamiento del grupo saliente con 5-aminotetrazol; y después hacer reaccionar opcionalmente con una base metálica, una amina, amoniaco o una base amínica cuaternaria farmacológicamente aceptables para formaruna sal farmacológicamente aceptable de un compuesto de fórmula I.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86956978A | 1978-01-16 | 1978-01-16 | |
US89373178A | 1978-04-05 | 1978-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES482421A1 true ES482421A1 (es) | 1980-04-01 |
Family
ID=27128123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES482421A Expired ES482421A1 (es) | 1978-01-16 | 1979-07-11 | Un procedimiento para la preparacion de nuevos derivados de prostaglandina. |
Country Status (28)
Country | Link |
---|---|
JP (1) | JPS54100378A (es) |
AR (1) | AR222817A1 (es) |
AT (1) | AT367755B (es) |
AU (1) | AU507853B2 (es) |
CA (1) | CA1152502A (es) |
CH (1) | CH635833A5 (es) |
DD (1) | DD141155A5 (es) |
DE (1) | DE2901476C3 (es) |
DK (1) | DK523378A (es) |
ES (1) | ES482421A1 (es) |
FI (1) | FI790120A (es) |
FR (1) | FR2414503A1 (es) |
GB (1) | GB2012272B (es) |
GR (1) | GR72747B (es) |
IE (1) | IE48175B1 (es) |
IL (1) | IL56433A (es) |
IN (1) | IN150279B (es) |
IT (1) | IT1110992B (es) |
LU (1) | LU80789A1 (es) |
NL (1) | NL7900292A (es) |
NO (1) | NO790122L (es) |
NZ (1) | NZ189377A (es) |
PH (3) | PH15031A (es) |
PL (1) | PL117869B1 (es) |
PT (1) | PT69076A (es) |
SE (1) | SE427657B (es) |
SU (1) | SU831071A3 (es) |
YU (1) | YU4579A (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE788209A (fr) * | 1971-09-01 | 1973-02-28 | Pfizer | Derives tetrazoyliques des prostaglandines naturelles |
DD118856A5 (es) * | 1972-11-08 | 1976-03-20 | ||
IE43462B1 (en) * | 1975-06-23 | 1981-03-11 | Pfizer | Substituted tetranorprostaglandins |
DE2559093C3 (de) * | 1975-12-30 | 1981-12-24 | Pfizer Inc., 10017 New York, N.Y. | 2-Desarboxy-2-[tetrazol-5-yl]-11-desoxy-ω-pentanorprostaglandine der E- oder F-Reihe und deren C↓15↓-Epimere |
US4404372A (en) * | 1977-06-13 | 1983-09-13 | Pfizer Inc. | 15-Substituted-ω-pentanorprostaglandin derivatives |
-
1978
- 1978-11-23 DK DK523378A patent/DK523378A/da not_active Application Discontinuation
- 1978-11-23 IN IN841/DEL/78A patent/IN150279B/en unknown
- 1978-12-27 PL PL1978212183A patent/PL117869B1/pl unknown
- 1978-12-27 DD DD78210198A patent/DD141155A5/de unknown
- 1978-12-27 SU SU782715902A patent/SU831071A3/ru active
-
1979
- 1979-01-11 YU YU00045/79A patent/YU4579A/xx unknown
- 1979-01-12 CA CA000319536A patent/CA1152502A/en not_active Expired
- 1979-01-12 PH PH22056A patent/PH15031A/en unknown
- 1979-01-12 JP JP286979A patent/JPS54100378A/ja active Pending
- 1979-01-15 GR GR58098A patent/GR72747B/el unknown
- 1979-01-15 IL IL56433A patent/IL56433A/xx unknown
- 1979-01-15 FI FI790120A patent/FI790120A/fi unknown
- 1979-01-15 CH CH38079A patent/CH635833A5/fr not_active IP Right Cessation
- 1979-01-15 AU AU43359/79A patent/AU507853B2/en not_active Ceased
- 1979-01-15 NZ NZ189377A patent/NZ189377A/xx unknown
- 1979-01-15 NL NL7900292A patent/NL7900292A/xx not_active Application Discontinuation
- 1979-01-15 AT AT0027579A patent/AT367755B/de not_active IP Right Cessation
- 1979-01-15 FR FR7900857A patent/FR2414503A1/fr active Granted
- 1979-01-15 SE SE7900353A patent/SE427657B/sv not_active IP Right Cessation
- 1979-01-15 NO NO790122A patent/NO790122L/no unknown
- 1979-01-15 IE IE60/79A patent/IE48175B1/en unknown
- 1979-01-15 LU LU80789A patent/LU80789A1/fr unknown
- 1979-01-15 PT PT69076A patent/PT69076A/pt unknown
- 1979-01-15 GB GB791428A patent/GB2012272B/en not_active Expired
- 1979-01-15 IT IT19290/79A patent/IT1110992B/it active
- 1979-01-16 AR AR275174A patent/AR222817A1/es active
- 1979-01-16 DE DE2901476A patent/DE2901476C3/de not_active Expired
- 1979-07-11 ES ES482421A patent/ES482421A1/es not_active Expired
- 1979-11-19 PH PH23299A patent/PH15653A/en unknown
- 1979-11-19 PH PH23301A patent/PH15643A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1409843A (en) | Prostaglandin intermediates | |
GB1427112A (en) | Antifouling compositions | |
ES8102129A1 (es) | Un procedimiento para preparar nuevos derivados heterocicli-cos | |
ES480151A1 (es) | Un procedimiento para la obtencion de nuevos azacicloalcanos. | |
EP0304966A3 (en) | Beta-ketonitriles | |
ES477784A1 (es) | Procedimiento para la preparacion de nuevas 2-fenilimino-imidazolidinas sustituidas. | |
ES489823A1 (es) | Procedimiento para la obtencion de un catalizador para la polimerizacion de butadieno | |
ES482675A1 (es) | Un procedimiento para la preparacion de nuevos derivados de oxadiazolopirimidina. | |
ES482421A1 (es) | Un procedimiento para la preparacion de nuevos derivados de prostaglandina. | |
GB1409648A (en) | Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof | |
GB1131164A (en) | Novel halogen-substituted tetrahydroquinazoline derivatives, their preparation and compositions containing them | |
GB1503447A (en) | Dl-and 8r-9-fluoro-prostadienoic acid derivatives and process | |
IE42653L (en) | Benzyl thioamides and their use as pesticides | |
GB1454737A (en) | Sulphonylcarbamoyl derivatives | |
ES468133A1 (es) | Procedimiento para preparar derivados del cornezuelo del centeno | |
ES478338A1 (es) | Procedimiento para la obtencion de derivados de disulfimida. | |
ES8609233A1 (es) | Procedimiento para preparar compuestos intermedios para ob- tener derivados de los acidos 16-fenoxi y 16-fenoxi susti- tuido-prostatrienoicos | |
EP0338587A3 (en) | Recording material | |
GB1265727A (es) | ||
IT1215251B (it) | Farmaceutiche che li contengono. composti ad attivita'antiaggregante piastrinica, procedimento per la loro preparazione e composizioni | |
ES459954A1 (es) | Procedimiento para la preparacion de derivados de ciclopro- pano. | |
GB1477125A (en) | Biphenylyl ethers and processes for their preparation | |
UA6020A1 (uk) | Спосіб одержання n-метіл-n-/2-(2-діметіламінометіл тіазол-4-ілметілтіо)-етіл/-2-нітро-1,1-етендіаміна | |
ES472997A1 (es) | Procedimiento para la obtencion de composiciones herbicidas a base de derivados de n-fenil-n -metil-n -metoxiurea | |
ES8705454A1 (es) | Procedimiento para la obtencion de derivados del acido imidazoalquenoico |